z-logo
open-access-imgOpen Access
History and Current Impact of Cardiac Magnetic Resonance Imaging on the Management of Iron Overload
Author(s) -
John C. Wood
Publication year - 2009
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.109.907196
Subject(s) - medicine , magnetic resonance imaging , context (archaeology) , heart failure , siderosis , cardiac magnetic resonance imaging , ferritin , risk stratification , cardiology , radiology , paleontology , biology
In this issue of Circulation , researchers from the Royal Brompton Hospital and University College London have published a long-anticipated report on the ability of magnetic resonance imaging (MRI) to predict cardiac dysfunction in transfusional siderosis.1Article see p 1961 Briefly, they report that a cardiac T2* value <10 ms had a sensitivity of 98% and a specificity of 86% for prediction of symptomatic heart failure in 1 year. Risk was graded with respect to T2*, with 47% of patients having T2* <6 ms developing cardiac failure in the same interval. Similar, but less striking, risk stratification was also observed for prospective arrhythmia risk. Metrics of total body iron stores, liver iron concentration, and serum ferritin performed little better than chance in predicting heart failure.To place these observations in context, it is important to review iron overload and its past and present management. Iron overload is a surprisingly common clinical problem, occurring through increased iron absorption (primary hemochromatosis) or through frequent blood transfusion therapy (secondary hemochromatosis).2 Primary hemochromatosis disorders, such as hfe mutations, are relatively common in white populations. However, variable hfe gene penetrance, increased genetic surveillance, and severity of noncardiac symptoms result in fewer hereditary hemochromatosis patients presenting with iron-mediated cardiac disease. By contrast, iron cardiomyopathy remains a major cause of death in secondary hemochromatosis disorders such as the thalassemia, Blackfan-Diamond anemia, and myelodysplastic syndromes because the iron-loading rates are many-fold greater than for primary hemochromatosis.3 The hemoglobinopathies are the most common genetic disorders in the world, particularly in regions where malaria is or was previously endemic, such as the Mediterranean, northern Africa, the Middle East, and Southeast Asia. Increasing economic and ethnic globalization has increased the importance of these disorders in the United States, and their impact is increasing. Iron overload is also becoming …

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom